What question did this study set out to answer?

This research aims to evaluate the influence of reverse transcriptase enzymes on molecular response classification in chronic myeloid leukemia.

December 8, 2025Blood

Evaluating reverse transcriptase efficiency in CML: Consequences for deep molecular response classification and treatment-free remission decisions

View Full Paper

Ask AI

Bookmark

This research aims to evaluate the influence of reverse transcriptase enzymes on molecular response classification in chronic myeloid leukemia.
Analyzed samples from 12 patients with chronic myeloid leukemia in deep molecular response.
Used seven different reverse transcriptase enzymes for cDNA synthesis.
Quantified ABL1, GUSB, and BCR::ABL1 transcripts via standardized RT-qPCR.
SuperScript II, High Capacity, and MMLV yielded consistent MR classification results according to ELN guidelines.
Other enzymes like GoTaq and GoScript produced insufficient ABL1 and GUSB copy numbers, affecting sensitivity.
Clara enzyme showed high variability and risk of false-negative results, making it unsuitable for clinical use.

No takes yet. Share an insight, caveat, or question.

Evaluating assay sensitivity and treatment discontinuation in chronic myeloid leukemia using reverse transcriptase.

Poláková et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark